XML 43 R33.htm IDEA: XBRL DOCUMENT v3.25.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2025
Net Loss per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share Attributable to Stockholders

The following table summarizes the basic and diluted net loss per share attributable to stockholders (in thousands, except share and per share data):

 

   Three Months Ended June 30, 2025   Three Months Ended June 30, 2024 
   Loss Allocation   Weighted
Average
Shares
Outstanding
   Loss Per
Share,
Basic and
Diluted
   Loss
Allocation
   Weighted
Average
Shares
Outstanding
   Loss Per
Share,
Basic and
Diluted
 
Common Stock  $(19,327)   42,095,951   $(0.46)  $(22,243)   3,197,975   $(6.96)
Company Series B Preferred Stock(1)   (5,247)   137,138   $(38.26)   
    
   $
 
Net loss  $(24,574)            $(22,243)          

 

(1)

The weighted-average number of shares of as-converted Company Series B Preferred Stock used in the loss allocation was 11,428,129 for the three months ended June 30, 2025.

 

   Six Months Ended June 30, 2025   Period from
February 6, 2024 (Inception) to
June 30, 2024
 
   Loss Allocation   Weighted
Average
Shares
Outstanding
   Loss Per
Share,
Basic and
Diluted
   Loss
Allocation
   Weighted
Average
Shares
Outstanding
   Loss Per
Share,
Basic and
Diluted
 
Common Stock  $(35,805)   41,888,906   $(0.85)  $(29,320)   3,197,975   $(9.17)
Company Series B Preferred Stock(1)   (9,768)   137,138   $(71.23)   
    
   $
 
Net loss  $(45,573)            $(29,320)          

 

(1) The weighted-average number of shares of as-converted Company Series B Preferred Stock used in the loss allocation was 11,428,129 for the six months ended June 30, 2025.
Schedule of Anti-Dilutive Effect Excluded from Potential Computation of Diluted Net Loss Per Share

The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to stockholders for the periods presented because including them would have had an anti-dilutive effect were as follows:

 

   Three
Months Ended
June 30,
2025
   Three
Months Ended
June 30,
2024
   Six Months Ended
June 30,
2025
   Period from
February 6, 2024
(Inception) to June 30,
2024
 
Outstanding convertible preferred stock (as converted to common stock)   
    11,428,149    
    11,428,149 
Outstanding employee warrants to purchase common stock   3,054,358    
    3,054,358    
 
Outstanding unvested restricted stock awards   1,493,010    2,207,553    1,493,010    2,207,553 
Outstanding and issued common stock options   3,668,560    1,179,193    3,668,560    1,179,193 
Outstanding and issued warrant to Paruka   596,930    
    596,930    
 
Total   8,812,858    14,814,895    8,812,858    14,814,895